The world of finance, connected.EN / Global
NE
CompanyCompany profileReviewed 2026-10-23

NEKTAR THERAPEUTICS

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.

Sources and references ↗
COMPANY PROFILE / 8 SOURCE-LINKED FIELDS

Basic company information

Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.

Company / filing name
NEKTAR THERAPEUTICS [1]
Headquarters location
San Francisco [2]
Founded
1990 [2]
Official website
www.nektar.com ↗ [2]
ISIN (reported securities)
US6402683063 [2]
CIK
906709 [1]
Country in background record
United States [2]
Symbols / exchanges
NKTR (Nasdaq) [1]

Company positioning and business

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. [3]

Background text: Wikipedia contributors, Nektar Therapeutics. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.

Financial year, securities and disclosures

Listed securities: NKTR (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [1]

History and key events

  1. Founding / inception date recorded in Wikidata. [2]

Financial results and regulatory disclosures

No individual financial documents have been indexed yet. Open the source to consult company disclosures. [1]

Related entities and concepts

Frequently asked questions

When was NEKTAR THERAPEUTICS founded?

Founded: 1990. The linked source provides the background record. [2]

Where is the headquarters of NEKTAR THERAPEUTICS?

Headquarters location: San Francisco. The linked source provides the background record. [2]

Sources and review dates

  1. Company identity and profile data ↗
  2. Wikidata — company background record (CC0) ↗
  3. Wikipedia contributors — Nektar Therapeutics (CC BY-SA 4.0) ↗

Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.

Content preparation: source-based compilation with AI assistance. See methods and attribution. Named sources identify the underlying records; no individual expert review is claimed.